Could a single daily pill deliver Parkinson’s medication?

News

Author: Simge Eva DoganPublished: 1 October 2020

Prep: Cook: Serves:

NTU Assoc Prof Joachim Loo and LiberaTx COO Shashi Kesavapany holding their new drug microcapules in their hands

Scientists at Nanyang Technological University, Singapore, have developed a new pill that could be used to slowly deliver medication over a 24-hour period to people living with Parkinson’s disease.

They hope that delivering Parkinson’s medication in this way could help manage symptoms which can occur when people experience ‘off’ periods between taking medications. A team at the university’s startup LiberaTx is now commercialising the technology and planning clinical trials to test the efficacy of the pill.

Joachim Loo (pictured left), associate professor at the university and founder of LiberaTx, said: “We hope that […] reducing dosage to just once-a-day would greatly improve patient compliance, lower the pill burden of these patients, while alleviating the ‘off’ periods that these patients experience. Achieving this would greatly improve quality of life for the patient.”

If the pill is proven successful for treating Parkinson’s disease, it may also be used for treating other conditions that require taking multiple drugs daily.

Lead image credit: NTU Singapore

Read more about the new pill for delivering Parkinson’s medication here.

For more information on the latest Parkinson’s research please visit the EPDA website.

Has Covid-19 impacted access to Parkinson’s medication?

Last Month

Next Month

Go Back

Share this story

Comments

Global update

Patients in video tribute to ‘knockout’ Ali Center

Patients pay tribute to 'knockout' Parkinson's treatment centre

Sexuality and Parkinson’s: the needs of caregivers

Tips for maintaining couple intimacy in Parkinson’s

Parkinson’s walking stick inventor granted entrepreneur visa after Home Office U-turn

‘Walk to Beat’ inventor granted visa to stay in the UK

Study suggests why neurons die in Parkinson’s disease

Researchers at the University of Córdoba, Spain, have discovered how a certain protein may be linked to death of dopamine-producing neurons associated with Parkinson’s. Using animal models of the condition to conduct their study, the team focused on the protein DJ-1 – whose link to Parkinson’s has previously been established, though its exact function was uncertain. The researchers compared neurons in the brains of mice that possessed the gene expressing DJ-1 with those that did not. The findings revealed that dysfunction or absence of the gene expressing the DJ-1 protein could trigger the ‘cell cycle’ (the process by which cells divide), which should not occur under normal conditions. Because neurons lack the capacity to divide, this causes them die – leading to the onset of symptoms linked with Parkinson’s. It is hoped that uncovering these details about the relationship between DJ-1’s absence and Parkinson’s may lead to the development of…

Researchers have finally identified brain cells linked to Parkinson’s disease

For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Could a single daily pill deliver Parkinson’s medication?

News

Author: Simge Eva DoganPublished: 1 October 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Global update

Patients in video tribute to ‘knockout’ Ali Center

Health & Fitness

Sexuality and Parkinson’s: the needs of caregivers

Perspectives

Parkinson’s walking stick inventor granted entrepreneur visa after Home Office U-turn

Study suggests why neurons die in Parkinson’s disease

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

{title}

Subscribe

Could a single daily pill deliver Parkinson’s medication?

News

Author: Simge Eva DoganPublished: 1 October 2020

Last Month

Next Month

Share this story

Comments

Related articles

Global update

Patients in video tribute to ‘knockout’ Ali Center

Health & Fitness

Sexuality and Parkinson’s: the needs of caregivers

Perspectives

Parkinson’s walking stick inventor granted entrepreneur visa after Home Office U-turn

Study suggests why neurons die in Parkinson’s disease

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

{title}

Subscribe

Sign in